These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 14662521)

  • 1. Regulation of proteins affecting NMDA receptor-induced excitotoxicity in a Huntington's mouse model.
    Jarabek BR; Yasuda RP; Wolfe BB
    Brain; 2004 Mar; 127(Pt 3):505-16. PubMed ID: 14662521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of postsynaptic density protein-95 with NMDA receptors influences excitotoxicity in the yeast artificial chromosome mouse model of Huntington's disease.
    Fan J; Cowan CM; Zhang LY; Hayden MR; Raymond LA
    J Neurosci; 2009 Sep; 29(35):10928-38. PubMed ID: 19726651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional dysregulation in striatal projection- and interneurons in a mouse model of Huntington's disease: neuronal selectivity and potential neuroprotective role of HAP1.
    Zucker B; Luthi-Carter R; Kama JA; Dunah AW; Stern EA; Fox JH; Standaert DG; Young AB; Augood SJ
    Hum Mol Genet; 2005 Jan; 14(2):179-89. PubMed ID: 15548548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P38 MAPK is involved in enhanced NMDA receptor-dependent excitotoxicity in YAC transgenic mouse model of Huntington disease.
    Fan J; Gladding CM; Wang L; Zhang LY; Kaufman AM; Milnerwood AJ; Raymond LA
    Neurobiol Dis; 2012 Mar; 45(3):999-1009. PubMed ID: 22198502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine D1-dependent trafficking of striatal N-methyl-D-aspartate glutamate receptors requires Fyn protein tyrosine kinase but not DARPP-32.
    Dunah AW; Sirianni AC; Fienberg AA; Bastia E; Schwarzschild MA; Standaert DG
    Mol Pharmacol; 2004 Jan; 65(1):121-9. PubMed ID: 14722243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complex alteration of NMDA receptors in transgenic Huntington's disease mouse brain: analysis of mRNA and protein expression, plasma membrane association, interacting proteins, and phosphorylation.
    Luthi-Carter R; Apostol BL; Dunah AW; DeJohn MM; Farrell LA; Bates GP; Young AB; Standaert DG; Thompson LM; Cha JH
    Neurobiol Dis; 2003 Dec; 14(3):624-36. PubMed ID: 14678777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced Akt signaling is an early pro-survival response that reflects N-methyl-D-aspartate receptor activation in Huntington's disease knock-in striatal cells.
    Gines S; Ivanova E; Seong IS; Saura CA; MacDonald ME
    J Biol Chem; 2003 Dec; 278(50):50514-22. PubMed ID: 14522959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in N-methyl-D-aspartate receptor sensitivity and magnesium blockade occur early in development in the R6/2 mouse model of Huntington's disease.
    Starling AJ; André VM; Cepeda C; de Lima M; Chandler SH; Levine MS
    J Neurosci Res; 2005 Nov; 82(3):377-86. PubMed ID: 16211559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scaffolding protein Homer1a protects against NMDA-induced neuronal injury.
    Wang Y; Rao W; Zhang C; Zhang C; Liu MD; Han F; Yao LB; Han H; Luo P; Su N; Fei Z
    Cell Death Dis; 2015 Aug; 6(8):e1843. PubMed ID: 26247728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of CGS 21680, a selective adenosine A(2A) receptor agonist, on NMDA receptor function and expression in the brain of Huntington's disease mice.
    Ferrante A; Martire A; Armida M; Chiodi V; Pézzola A; Potenza RL; Domenici MR; Popoli P
    Brain Res; 2010 Apr; 1323():184-91. PubMed ID: 20138162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-methyl-D-aspartate receptor subunit- and neuronal-type dependence of excitotoxic signaling through post-synaptic density 95.
    Fan J; Vasuta OC; Zhang LY; Wang L; George A; Raymond LA
    J Neurochem; 2010 Nov; 115(4):1045-56. PubMed ID: 20831617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted disruption of PSD-93 gene reduces platelet-activating factor-induced neurotoxicity in cultured cortical neurons.
    Xu Y; Zhang B; Hua Z; Johns RA; Bredt DS; Tao YX
    Exp Neurol; 2004 Sep; 189(1):16-24. PubMed ID: 15296832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuronal vulnerability in mouse models of Huntington's disease: membrane channel protein changes.
    Ariano MA; Wagle N; Grissell AE
    J Neurosci Res; 2005 Jun; 80(5):634-45. PubMed ID: 15880743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease.
    Zeron MM; Hansson O; Chen N; Wellington CL; Leavitt BR; Brundin P; Hayden MR; Raymond LA
    Neuron; 2002 Mar; 33(6):849-60. PubMed ID: 11906693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection by cholesterol-extracting cyclodextrins: a role for N-methyl-D-aspartate receptor redistribution.
    Abulrob A; Tauskela JS; Mealing G; Brunette E; Faid K; Stanimirovic D
    J Neurochem; 2005 Mar; 92(6):1477-86. PubMed ID: 15748165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Motor impairments, striatal degeneration, and altered dopamine-glutamate interplay in mice lacking PSD-95.
    Zhang J; Saur T; Duke AN; Grant SG; Platt DM; Rowlett JK; Isacson O; Yao WD
    J Neurogenet; 2014; 28(1-2):98-111. PubMed ID: 24702501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-synaptic density-95 promotes calcium/calmodulin-dependent protein kinase II-mediated Ser847 phosphorylation of neuronal nitric oxide synthase.
    Watanabe Y; Song T; Sugimoto K; Horii M; Araki N; Tokumitsu H; Tezuka T; Yamamoto T; Tokuda M
    Biochem J; 2003 Jun; 372(Pt 2):465-71. PubMed ID: 12630910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in expression of N-methyl-D-aspartate receptor subunits occur early in the R6/2 mouse model of Huntington's disease.
    Ali NJ; Levine MS
    Dev Neurosci; 2006; 28(3):230-8. PubMed ID: 16679770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective up-regulation of CK2 by mutant huntingtin in cells co-expressing NMDA receptors.
    Fan MM; Zhang H; Hayden MR; Pelech SL; Raymond LA
    J Neurochem; 2008 Feb; 104(3):790-805. PubMed ID: 17971125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine D1 receptor-dependent trafficking of striatal NMDA glutamate receptors to the postsynaptic membrane.
    Dunah AW; Standaert DG
    J Neurosci; 2001 Aug; 21(15):5546-58. PubMed ID: 11466426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.